Welcome to a Novartis-organised virtual scientific standalone meeting ‘The past, present and future in neovascular age-related macular degeneration’ on September 19th 2020.

An independent steering committee has led the development of the program for this scientific meeting, who will also lead the presentations and topical discussions. 

The main objective of this one-day virtual meeting is to provide education and insights on the latest advances in the treatment of neovascular age-related macular degeneration (nAMD), based on scientific evidence and illustrated by relevant cases of nAMD. European wide experiences of the impact of COVID19 on the management of nAMD will also be shared.

We look forward to welcoming you at this meeting. 

Novartis Region Europe Ophthalmology


Chairs:

Morning session – Dr Roberto Gallego-Pinazo and Prof. Ramin Tadayoni
Afternoon session – Prof. Sandrine Zweifel and Dr Konstantinos Balaskas    


Steering Committee:

  1. Dr Konstantinos Balaskas, UK   
  2. Prof. Usha Chakravarthy, UK    
  3. Dr Roberto Gallego-Pinazo, Spain    
  4. Dr Thomas Ach, Germany    
  5. Prof. Hans Hoerauf, Germany
  6. Prof. Laurent Kodjikian, France
  7. Prof. Giovanni Staurenghi, Italy    
  8. Prof. Ramin Tadayoni, France    
  9. Prof. Sandrine Zweifel, Switzerland    
Program 
09:30–09:35
Chairs’ Welcome
Roberto Gallego-Pinazo & Ramin Tadayoni
Session 1: The Past & Present
09:35-09:50
Evolution of anti-VEGF therapies to present
Ramin Tadayoni
09:50-10:10
Unmet needs in neovascular AMD therapy - perspectives
Thomas Ach
10:10–10:35
1. Current classification of neovascular AMD (10 mins)
Roberto Gallego-Pinazo
2. Treatment algorithms in the management of neovascular AMD (15 mins)
Giovanni Staurenghi
10:35-10:50
Q&A
Both Chairs and presenters
10:50-11:00
Break
11:00-12:00
Real world experience
Case discussions 1 (10 mins)
Thomas Ach
Case discussions 2 (10 mins)
Hans Hoerauf
Case discussions 3 (10 mins)
Roberto Gallego-Pinazo
Q&A on case presentations (15 mins)
Both Chairs and presenters
Panel discussion on cases (15 mins)
Both Chairs and presenters
12:00-12:55
Lunch break
12:55-13:00
Chairs’ Welcome
Sandrine Zweifel & Konstantinos Balaskas
Session 2: The Future
13:00–13:20
Addressing unmet needs in ophthalmology usingdigital technology
1. Artificial intelligence (10 mins)
Konstantinos Balaskas
2. Remote-monitoring (10 mins)
Sandrine Zweifel
13:20-13:30
Novel anti-VEGF treatments for neovascular AMD
Laurent Kodjikian
13:30-13:55
Q&A
Both Chairs and presenters
13:55-14:05
Break
14:05-14:30
1. Real-world outcomes and clinical trial findings
Usha Chakravarthy
2. Is fluctuation in retinal leakage and its compartmentalization important in nAMD?
Usha Chakravarthy
14:30-14:50
Country perspectives and learnings from COVID-19with respect to neovascular AMD management (5 mins per presenter)
France: Laurent Kodjikian
Germany: Hans Hoerauf
UK: Usha Chakravarthy
Italy: Giovanni Staurenghi
14:50-15:15
Panel discussion (including recommendations on post-COVID-19 landscape) (5 mins)
Moderated by both Chairs
General Q&A for Future Session (20 mins)
Both Chairs and presenters
15:15–15:30
Closing remarks
SE2008144374 (14 augusti 2020)
×

Medical Information Request

×

Ask Speakers

Anmälan: The Past, Present and Future in Neovascular Age-related Macular Degeneration

 

Genom att anmäla dig till mötet accepterar du att vi behandlar dina uppgifter i enlighet med vår integritetsskyddspolicy.